The frontline combination of zanidatamab-hrii (Ziihera) and chemotherapy with or without tislelizumab (Tevimbra) was ...
Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback